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Abstract
We have previously identified the scaffold protein liprin-a1 as an important regulator of integrin-mediated cell motility and
tumor cell invasion. Liprin-a1 may interact with different proteins, and the functional significance of these interactions in the
regulation of cell motility is poorly known. Here we have addressed the involvement of the liprin-a1 partner GIT1 in liprin-
a1-mediated effects on cell spreading and migration. GIT1 depletion inhibited spreading by affecting the lamellipodia, and
prevented liprin-a1-enhanced spreading. Conversely inhibition of the formation of the liprin-a1-GIT complex by expression
of liprin-DCC3 could still enhance spreading, although to a lesser extent compared to full length liprin-a1. No cumulative
effects were observed after depletion of both liprin-a1 and GIT1, suggesting that the two proteins belong to the same
signaling network in the regulation of cell spreading. Our data suggest that liprin-a1 may compete with paxillin for binding
to GIT1, while binding of bPIX to GIT1 was unaffected by the presence of liprin-a1. Interestingly, GIT and liprin-a1
reciprocally regulated their subcellular localization, since liprin-a1 overexpression, but not the GIT binding-defective liprin-
DCC3 mutant, affected the localization of endogenous GIT at peripheral and mature central focal adhesions, while the
expression of a truncated, active form of GIT1 enhanced the localization of endogenous liprin-a1 at the edge of spreading
cells. Moreover, GIT1 was required for liprin-a1-enhanced haptotatic migration, although the direct interaction between
liprin-a1 and GIT1 was not needed. Our findings show that the functional interaction between liprin-a1 and GIT1 cooperate
in the regulation of integrin-dependent cell spreading and motility on extracellular matrix. These findings and the possible
competition of liprin-a1 with paxillin for binding to GIT1 suggest that alternative binding of GIT1 to either liprin-a1o r
paxillin plays distinct roles in different phases of the protrusive activity in the cell.
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Introduction
Cell migration requires complex molecular events that need to
be finely regulated in time and space [1]. GIT1 (G protein-coupled
receptor kinase-interacting protein 1) and GIT2/PKL form a
family of multi-domain ArfGAP proteins with scaffolding acti-
vity, which are implicated in the regulation of cell adhesion and
migration on extracellular matrix [2]. They interact via an SHD
(Spa2 homology domain) with the components of the PIX (p21-
activated kinase-interacting exchange factor) family of guanine
nucleotide exchanging factors for Rac and Cdc42 GTPases [3–5].
Moreover, the carboxy-terminal region of GIT proteins can
interact with the adaptor proteins paxillin [6,7] and liprin-a1 [8],
both implicated in the formation and turnover of integrin-
mediated FAs (focal adhesions) [9–11].
GIT proteins are involved in different pathways that regulate
cell motility. For example, GIT1 is involved in EGF-dependent
vascular smooth muscle cell migration [12], while the second
member of the family, GIT2 is a key player for chemotactic
directionality in stimulated neutrophils [13], and is required for
PDGF-dependent directional cell migration and cell polarity, but
not for random migration [14].
It has been proposed that GIT1 may cycle between at least
three distinct subcellular compartments, including FAs, leading
edge, and cytoplasmic compartments, and the functional interac-
tion between GIT1, bPIX and PAK has been associated to cell
protrusive activity and migration [15,16]. On the other hand, the
precise function of the GIT complexes in cell motility is still
insufficiently understood, and existing findings have led to con-
flicting reports on whether the recruitment of GIT-mediated
complexes positively [17] or negatively [18] affect Rac-mediated
protrusion.
The localization of GIT1 at the leading edge may play a role in
recruiting the GTPase activator bPIX and the Rac effector PAK
at the same location, thus restricting the activity of Rac1 to the
front of motile cells where actin assembly is needed [19–21]. It has
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border, and that the GIT1/PIX/PAK complex is recruited by the
FA protein paxillin at dynamic peripheral adhesive structures to
regulate their turnover [17].
Liprins are a family of scaffold proteins that include the liprin-a
and -b subfamilies [10]. Liprin-a proteins are multi-domain
proteins that can interact directly with several binding partners.
Recent work has revealed that liprin-a1 is an essential regulator
of cell motility and tumor cell invasion [11,22–24] but the exact
implication and role of the different liprin-a/partner complexes in
the regulation of cell motility are poorly understood [25]. We have
shown that the interaction of GIT1 with liprin-a1 and paxillin
must be regulated. In fact, both liprin-a1 and paxillin interact
poorly with the full length GIT1 protein, while they interact
efficiently with carboxy-terminal fragments of GIT1 or with GIT1
polypeptides with limited internal deletions [26], suggesting that
GIT1 function is regulated by an intramolecular mechanism.
Accordingly, overexpression of the ‘‘active’’ truncated GIT1-C
protein, but not the full length protein, leads to enhanced cell
spreading [26].
In this study we have analyzed the biochemical and functional
interaction between liprin-a1 and GIT1 to explore the role of this
interaction in cell motility. By co-immunoprecipitation experi-
ments we have shown that GIT1 may form alternative complexes
with either paxillin or liprin-a1. Moreover, we found that GIT1 is
required for liprin-a1-mediated cell spreading and migration,
although the direct interaction between the two proteins does not
appear to be essential for these processes. Finally, we demonstrated
a reciprocal effect of liprin and GIT on their localization at FAs at
the cell edge, which correlated with the ability of the two proteins
to interact with each other.
Results and Discussion
Liprin-a1 interferes with the binding of paxillin, but not
of bPIX to GIT1
Regions of interaction between liprin-a1 and GIT1 have been
previously identified by a yeast two-hybrid assay. A central
fragment of liprin-a1 (amino acid residues 603–673) interacted
with the carboxy-terminal region of GIT1, and the interaction
between the two full-length proteins was confirmed by co-
immunoprecipitation from lysates from HEK-293T cells or from
the synaptosomal fraction of adult rat brain [8,27]. By further
investigating the interaction of GIT1 with liprin-a1, we
confirmed the interaction of liprin-a with the carboxy-terminal
part of GIT1 by pull down from embryonic chick brain lysates
with the ZZ-GIT1-C2 fusion protein pre-bound to IgG-
Sepharose. A specific band of about 160 kDa was eluted from
IgG beads coupled to ZZ-GIT1-C2 compared to control IgG
beads (Fig. S1, A). Mass spectroscopy analysis of this band
revealed several peptides corresponding to peptide sequences of
the human liprin-a2 protein (Fig. S1, B), a member of the liprin-a
family prevalently expressed in neural tissue. This finding
confirms previous results on the identification of the interaction
of liprin-a proteins with GIT1 [8]. Here, for the following
functional and biochemical analysis we have then switched to
consider the ubiquitously expressed liprin-a1 protein. Since
overexpressed liprin-a1 interacts poorly with overexpressed full
length GIT1, but efficiently with the GIT1-C2 carboxy-terminal
polypeptide [26], we further investigated the requirements for the
interaction between the two proteins by co-transfecting COS7
cells with one of several GIT1 truncation mutants together with
either full length liprin-a1 or with the Myc-tagged liprin-F3
fragment (amino acid residues 347–675 of human liprin-a1) that
includes the GIT1-binding region (Fig. S1, G–H). An extended
carboxy-terminal fragment was required for reproducible and
efficient co-immunoprecipitation of the two proteins from cell
lysates (Fig. S1, C,E–F). Carboxy-terminal fragments shorter than
GIT1-C gave weak or no interaction with liprin-a1. In particular,
immunoprecipitation of Myc-liprin-F3 from co-transfected cells
showed no interaction between the liprin-a1 fragment and
FLAG-GIT1(512–740) (Fig. S1, E). The interaction was absent
also in reciprocal immunoprecipitations using anti-FLAG anti-
bodies (data not shown).
Paxillin interacts with the carboxy-terminal region of rat GIT1
including residues 640–770 (residues 610–740 in chick GIT1) via
the LD motifs [7,28]. As expected, endogenous paxillin co-
precipitated with FLAG-GIT1(512–740) that includes the full
paxillin binding region [7] (Fig. S1, E). On the other hand,
constructs including short deletions at the carboxy-terminus
[FLAG-GIT1(229–680) and FLAG-GIT1(229–667)] abolished
the interaction with both liprin-a1 and paxillin (Fig. S1, C–D).
Altogether the results show that an extended region of the
carboxy-terminal portion of GIT1 is required for efficient inter-
action with liprin-a1, and that the region of GIT1 required for the
binding to liprin-a1 includes the paxillin-binding region.
Based on these findings, we tested the hypothesis that liprin-a1
may interfere with the binding of paxillin to the carboxy-terminus
of GIT1 in the cell. For this, we first immunoprecipitated
endogenous paxillin from lysates of cells transfected either with
HA-GIT1-C2 alone, or with both HA-GIT1-C2 and full length
FLAG-liprin-a1. Under conditions in which endogenous paxillin
was virtually immunodepleted from lysates (Fig. 1, A, panels a and
b), the interaction of paxillin with HA-GIT1-C2 was strongly
reduced in the lysates from co-transfected cells (Fig. 1, A, panel a).
We then tested the hypothesis that the decrease of binding of
paxillin to GIT1-C2 may be due to binding of the overexpressed
liprin-a1 to GIT1-C2 itself. For this, the unbound fraction after
immunoprecipitation with anti-paxillin from lysates of cells co-
transfected with HA-GIT1-C2 and FLAG-liprin-a1, was used in a
second round of immunoprecipitation with anti-liprin-a1 antibody
(Fig. 1, A, panel c). This immunoprecipitation showed a strong
interaction of FLAG-liprin-a1 with HA-GIT1-C2 (Fig. 1, A, panel
c). These data suggest that binding of overexpressed liprin-a1t o
the carboxy-terminal portion of GIT1 interferes with the binding
of paxillin to the same region of GIT1, and indicate that the
formation of a trimeric liprin-a1/GIT1/paxillin complex in the
cell is not likely.
GIT1 and bPIX form stable hetero-complexes in COS7 cells
[26]. We thus tested if bPIX binding to the SHD domain of GIT1
interfered with the binding of liprin-a1 to the contiguous GIT1
carboxy-terminus. We used co-immunoprecipitation from trans-
fected cell lysates to test for the possible interference between
liprin-a1 and bPIX binding to GIT1. COS7 cells co-transfected
with HA-GIT1-C2 and HA-bPIX, with HA-GIT1-C2 and FLAG-
Liprin-a1, or triple-transfected with HA-GIT1-C2, HA-bPIX
and FLAG-Liprin-a1 were immunoprecipitated with anti-FLAG
antibodies. Similar amounts of GIT1-C2 were co-immunoprecip-
itated with anti-liprin-a1 antibodies in the presence or absence of
bPIX, indicating that binding of liprin-a1 to GIT1-C2 did not
affect the interaction of GIT1-C2 with bPIX (Fig. 1, B). These
results indicate that GIT1 may be found in complex with both
bPIX and liprin-a1 at the same time. On the other side, we found
that immunoprecipitation of bPIX from co-transfected cells
resulted in efficient co-precipitation of GIT1-C2 both in the
presence and absence of liprin-a1 (Fig. 1, C). These results show
that a trimeric bPIX/GIT1/Liprin-a1 complex may form in the
cell.
Liprin-a1 and GIT1 Regulate Migration
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20757Figure 1. Binding of liprin-a1 to GIT1-C2 prevents binding of paxillin to GIT1-C2. (A) Lysates were prepared from COS7 cells transfected
with either HA-GIT1-C2 (C2) or co-transfected with HA-GIT1-C2 and FLAG-liprin-a1( C 2 +Lip). Aliquots of the lysates were used for
immunoprecipitation with anti-paxillin antibodies (IP anti-paxillin, 400 mg of protein per IP). Filters with immunoprecipitates (a), and with 100 mg
of both lysates (Lys) and unbound fractions after IP (Ub) (b) were cut and immunoblotted with anti-Flag to detect Flag-liprin-a1 (upper filters, only
one of the duplicated immunoprecipitations is shown); since GIT1-C2 and paxillin migrate at similar positions on gels, the lower parts of the filters
from the duplicated immunoprecipitations were used as follows: one set of filters (a+b) was incubated with anti-HA to detect HA-GIT1-C2 (middle
blots), and one set was incubated with anti-paxillin to detect endogenous paxillin (lower blots). Paxillin was absent from the unbound fractions after
immunoprecipitation (Ub). (c) The unbound fraction (300 mg) after immunoprecipitation with anti-paxillin from the lysate of cells co-transfected with
HA-GIT1-C2 and FLAG-liprin-a1 [Ub(C2+Lip)], was re-immunoprecipitated with anti-liprin antibody, to reveal the presence of the liprin-a1/GIT1-C2
complex in the lysate. (B) Binding of liprin-a1 to GIT1-C2 does not prevent binding of bPIX to GIT1-C2. Identification of a ternary complex among
liprin-a1, bPIX and GIT1-C2. COS7 cells co-transfected to express the indicated combinations of HA-GIT1-C2, HA-bPIX, and FLAG-liprin-a1 were
immunoprecipitated with anti-FLAG antibodies (top blots on the left). Aliquots of the unbound fraction after the first round of immunoprecipitations
were re-immunoprecipitated with anti-bPIX antibodies (top blots on the right). Filters including immunoprecipitations (IP), lysates (Lys), and unbound
fractions after the second round of immunoprecipitations (Ub) were cut and blotted as indicated (lower blots). (C) Liprin-a1 does not interfere with
the interaction of bPIX with GIT-C2. COS7 cells co-transfected to express the indicated combinations of HA-GIT1-C2, HA-bPIX, and FLAG-liprin-a1 were
immunoprecipitated with anti-bPIX antibodies. Filters including aliquots of lysates and the immunoprecipitations (IP) were cut and blotted as
indicated. (D) A COS7 cell lysate (1 mg protein) was immunoprecipitated with anti-bPIX antibodies. Immunoprecipitate (IP) and equal amounts
(100 mg) of lysate (Lys) and unbound fraction (Ub) were blotted with anti-GIT (mAb PKL, recognizing both GIT1 and GIT2 proteins, on the left; or anti-
GIT2-specific pAb, on the right), bPIX, or anti-liprin-a1 antibodies. Blot with anti-GIT antibody was performed after stripping the filter incubated for
bPIX. (E) binding of bPIX to full length GIT1 does not enhance the binding of liprin-a1 to GIT1. COS7 cells were co-transfected with FLAG-liprin-a1 and
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genous or overexpressed GIT1/bPIX complexes is usually
undetectable and requires GIT1 activation by unknown mecha-
nisms. Likewise, liprin-a1 interacts poorly with full length GIT1,
while interacts efficiently with GIT1 deletion mutants that mimic
an activated form of GIT1 [26]. As for paxillin, we could not
detect the interaction of endogenous liprin-a1 with the endoge-
nous GIT/PIX complexes after immunoprecipitation from COS7
lysates (Fig. 1, D). Moreover, as already shown for paxillin, co-
expression of bPIX did not improve the association of overex-
pressed liprin-a1 to overexpressed full length GIT1 (Fig. 1, E).
Therefore, we can conclude that binding of bPIX to GIT1 is not
sufficient to activate the binding of these ligands to the carboxy-
terminal portion of GIT1.
We have previously hypothesized that activation of GIT1 by so
far unknown mechanisms is required for the formation of either
GIT1/paxillin or GIT1/liprin-a1 complexes [26]. Altogether, the
biochemical analysis described here indicates that the region of
contact between liprin-a1 and GIT1 involves the carboxy-terminal
half of the GIT1 polypeptide. These data also confirm the hypo-
thesis that bPIX may represent a stable partner of GIT1, while
GIT1 may change its carboxy-terminal partners according to the
cell’s requirements (Fig. 1, F). This model is also supported by our
previous data indicating that in contrast to endogenous paxillin,
most if not all endogenous bPIX is found in complex with
endogenous GIT1 proteins in COS7 cells [26]. The mechanisms
for the proposed intramolecular switch are unknown. Since our
published work indicates the association of the aminoterminal
portion of GIT1 to the carboxyterminal part of the protein, one
possibility is that the ArfGAP domain is not only structurally, but
also functionally relevant for the activation of GIT1. It is also
worth noting that in lysates from cells overexpressing GIT1 minor
specific bands of lower molecular weight are detectable (Fig. S1,
C). Although we noticed that the abundance of these fragments
may vary in different experiments, one can not rule out at this
point that an alternative way to activate GIT1 may derive from
the proteolytic cleavage of the full length protein to produce one or
more types of active carboxyterminal fragments, which could be
able to bind either paxillin or liprin.
GIT1 is required for efficient liprin-a1-mediated cell
spreading
Liprin-a1 is a regulator of cell motility required for the efficient
integrin-mediated spreading of COS7 cells [11]. COS7 cells
express mainly GIT1, and very little GIT2 (Fig. 1, D). We depleted
endogenous GIT1 by specific siRNAs (short interfering RNAs)
to analyze the effects on cell spreading. GIT1 silencing caused
both a strong decrease of the endogenous protein (Fig. 2, A; Fig.
S2), and loss of GIT signal from FAs (Fig. 2, B). It has been
previously shown that GIT1 silencing by siRNA inhibits the rate
of protrusion, while enhancing the stability and reducing the
turnover of FAs [17]. Here, we show that GIT1 depletion
inhibited COS7 cell spreading on FN (fibronectin) by negatively
affecting the formation of lamellipodia and of paxillin-positive FAs
at the cell edge (Fig. 2, C and Fig. S2), as previously observed after
liprin-a1 silencing [11]. Quantitative analysis showed similar
effects on spreading after depletion of either or both proteins
(Fig. 2, D). Interestingly, no additive inhibitory effects on
spreading were detected after double knockdown of liprin-a1
and GIT1 (Fig. 2, C–D), suggesting that these proteins participate
into the same signaling pathway for the regulation of cell edge
dynamics. In contrast to the positive effect of GIT1 in COS7 cell
spreading, silencing of GIT2 causes an increase in spreading in
HeLa cells, indicating that GIT2, but not GIT1, is an essential
inhibitor of cell spreading and FA turnover in these cells [29].
GIT2 also inhibits cell migration, since its silencing results in a
dramatic increase of transwell migration [29].
We previously found that over-expression of liprin-a1 enhances
COS7 cell spreading on FN, and that this effect is prevented by
depletion of the tyrosine phosphatase LAR (leukocyte common
antigen-related), a binding partner of liprin-a1 [11]. Similarly,
we found here that silencing of GIT1 alone or in combination with
LAR knockdown prevented liprin-a1-enhanced cell spreading
(Fig. 2, A,E). These data support the hypothesis that GIT1 and
LAR contribute with liprin-a1 to regulate integrin-mediated
spreading on extracellular matrix as part of a common signaling
network.
Liprin-a1 overexpression is known to enhance the spreading
of COS7 cells. We tested two different fragments of liprin-a1t o
identify regions of the protein responsible for the effects on
spreading: the central liprin-F3 fragment (amino acid residues
347–675), including the GIT1-binding region (Fig. S1, G) [27],
and the carboxy-terminal liprin-F1F2 fragment including the three
SAM (sterile alpha motif) domains (Fig. S3, A). We found that
liprin-F3 was sufficient to change the morphology of the cells and
to enhance spreading on FN and lamellipodia, while liprin-F1F2
had no evident effects on spreading or lamellipodia (Fig. S3, B–C).
We then tested if the direct interaction of GIT1 with liprin-a1
was necessary for the positive effects of liprin-a1 on cell spreading.
We compared spreading of cells transfected with either full length
liprin-a1 or liprin-DCC3, a deletion mutant that interacted poorly
with the carboxy-terminal portion of GIT1, as detected by
coimmunoprecipitation experiments (Fig. S4, A). Liprin-DCC3
includes the deletion of residues 615–673 of liprin-a1, a predicted
coiled coil region included in the smallest fragment of liprin-a1
interacting with GIT1 [27]. Like the full length protein, also liprin-
DCC3 remained associated to the cytoplasmic side of the plasma
membrane of cells, prepared by hypotonic shock as described
previously [30] (Fig. S4, B). This finding shows that the interaction
with GIT1 is not needed for the localization of liprin-a1 at the
cytoplasmic face of the plasma membrane of adherent cells.
The disruption of the interaction of liprin-a1 with GIT1 only
mildly reduced the positive effects of liprin-a1 overexpression
(Fig. S4, C), thus resulting in a more limited enhancement of
spreading and F-actin-positive lamellipodia compared to the full
length liprin-a1 (Fig. S4, D–E). These results suggest that,
although not crucial for liprin-a1-induced spreading and F-actin
reorganization at the cell edge, the association of GIT1 to liprin-
a1 supports the efficiency of these processes. Therefore, the
requirement of GIT1 for cell spreading is at least partially
independent from its physical association to liprin-a1.
FA turnover at the cell edge is important for cell motility and
spreading. Liprin-a1-induced active b1 integrin redistribution at
the ventral surface of adhering cells correlates with increased
FLAG-GIT1, or with FLAG-liprin-a1 and FLAG-GIT1 and HA-bPIX. 200 mg of each lysate were immunoprecipitated with anti-GIT1 antiserum. Lysates
(Lys, 50 mg), unbound fractions (Ub, 50 mg) and immunoprecipitates were blotted and incubated with antibodies specific for the indicated proteins.
Overexpression of bPix did not increase the interaction of liprin-a1 with GIT1. (F) Model for the regulated interaction of GIT1 with paxillin and liprin-
a1. Either ligand binds poorly to full length GIT1. We hypothesize that activation of GIT1 by so far unknown mechanisms is required for the formation
of either GIT1/paxillin or GIT1/liprin-a1 complexes.
doi:10.1371/journal.pone.0020757.g001
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with the 9EG7 mAb specific for the activated b1 integrins (Fig. S5,
A), or by antibodies for paxillin (Fig. S5, B) showed that like liprin-
a1 full length, also liprin-DCC3 induced a decrease of the cell area
occupied by FAs, and their relocalization at the cell edge. The
quantification showed that liprin-DCC3-expressing cells had a
less pronounced decrease of the total FA area (Fig. S5, C), and
less evident accumulation of new FAs at the cell edge (Fig. S5, D).
This was reflected by a higher fraction of liprin-DCC3-expressing
cells with low density of FAs at the cell edge (Fig. S5, E). There-
fore, although the interaction between GIT1 and liprin-a1 is not
essential for the redistribution of FAs induced by liprin-a1
overexpression, it appears to affect the efficiency of this process.
Liprin and GIT reciprocally regulate their subcellular
localization
As previously reported [4,16], we found that endogenous GIT1
localized with paxillin to peripheral and central FAs in COS7 cells
(Fig. 2, B). Intriguingly, endogenous GIT1 was relocalized fol-
lowing overexpression of liprin-a1 (Fig. 3, A). The localization of
GIT1 was decreased both at the newly formed small FAs at the
edge of spreading cells, as well as at central, mature FAs (Fig. 3, B–
C). Liprin-a1 overexpression caused the specific loss of endoge-
nous GIT from FAs, while endogenous FAK (Fig. 3, B–C) and
paxillin (data not shown) remained at FAs. Also in HeLa cells, the
effect of liprin-a1 overexpression was the specific removal of GIT
from FAs, while the localization at FAs of paxillin and talin was
not affected (Fig. S6). Interestingly, liprin-DCC3 expression did
not affect the localization of endogenous GIT1 at peripheral FAs
in COS7 cells (Fig. 3, B–C). In fact, while overexpression of the full
length liprin-a1 caused a reduction of the localization of endo-
genous GIT1 at FAK-positive FAs, leaving a diffuse cytoplasmic
signal for endogenous GIT, in cells expressing liprin-DCC3 GIT1
remained at peripheral FAK-positive FAs (Fig. 3, B–C). These
data indicate that the direct interaction of liprin-a1 with GIT1 is
required for the removal of GIT1 from FAs.
We have previously shown that GIT1 exists in an inactive state,
with poor binding capacity for paxillin or liprin-a1, even when
overexpressed together with bPIX in COS7 cells. On the other
hand we have previously shown that different deletions within the
GIT1 polypeptide induced more efficient binding of either paxillin
or liprin-a1 to GIT1 [26]. Activation was detectable as the
increased binding of paxillin and liprin-a1 to those deletion
constructs with respect to binding to the full length GIT1. In these
‘‘activated’’ mutants all or part of the aminoterminal region of the
GIT1 polypeptide had been removed, leaving the full carboxy-
terminal portion of the protein [26]. All the data obtained by us
on the putative active form of GIT1 have the limitation of being
derived from the deletion of a significant part of the GIT1
polypeptide that may affect the overall structure of the protein. On
the other hand, the preservation in these mutants of efficient
binding to established GIT1 partners such as paxillin and liprin-a1
[8,26,31] is indicative of the fact that a transition between an
inactive (poor binding to partners) and an active state (efficient
binding to partners) may exist in the full length protein. The
work by Ko et al. has shown for the first time the co-
immunoprecipitation of the full length GIT1 and liprin-a1
proteins from transfected HEK293 cells [8] and from a syna-
ptosomal fraction of adult rat brain [27]. This apparent
incongruity with our model of GIT1 activation may be due to
the different lysates used, and/or the different experimental
conditions for immunoprecipitation used in the two laboratories.
On the other hand, it can not be excluded that the interactions
observed in these studies may simply reflect the less efficient
binding of liprin-a1 to what we have defined as the inactive form
of GIT1. Therefore, the existence of a physiologically relevant
intramolecular mechanism for the activation of GIT1 at proper
places and times in the cell remains an intriguing open question.
To prove if this hypothesis reflects the way GIT1 is turned on in
the cell, and to test whether the proposed activation occurs by
an intramolecular conformational change or by proteolytic
cleavage of the GIT1 polypeptide will require further experimental
evidence.
Among the ‘‘activated’’ forms of GIT1, we have shown that
GIT1-C (Fig. S1, H, amino acid residues 346–740) was able to
specifically increase cell spreading and the reorganization of the
cell edge, while overexpression of the full length protein did not
show evident effects on spreading when compared to control cells
(Fig. 4, A–B). Similar to what we observed after liprin-a1
overexpression, GIT1-C induced the loss of paxillin-positive FAs
from the central part of the spreading cell, and the concentration
of paxillin-positive small FAs at the cell edge (Fig. 4, A). To further
examine the interplay between liprin-a1 and GIT1 during cell
spreading, we tested the effects of the expression of the truncated
active GIT1-C protein on the localization of endogenous liprin-a1
at the cell edge of spreading cells. The expression of GIT1-C,
which can bind either paxillin or liprin-a1 (Fig. S1), was able to
enhance the accumulation of endogenous liprin-a1 to the cell
edge, where liprin partially colocalized with the paxillin-positive
FAs (Fig. 4, C). The colocalization of liprin-a1 with paxillin-
positive FAs was much more evident in cells transfected with
GIT1-C compared to control cells.
Altogether these data indicate that liprin-a1 and activated GIT1
may reciprocally affect each other’s distribution at/near the cell
edge during active integrin-mediated cell motility. Liprin-a1
overexpression decreases the localization of endogenous GIT1 at
both peripheral, and mature central FAs in spreading cells. On the
other hand, the expression of an active form of GIT1 induces the
concentration ofendogenousliprin-a1 attheedge ofspreadingcells.
Wehypothesize that thisinterplaybetweenliprin-a1 andGIT1 may
be necessary for the dynamic reorganization of the adhesive sites
and the cytoskeleton of spreading cells, thus possibly promoting the
turnover of FAs. The changes in the organization of the cell edge
observed when the levels of either protein were altered, and the
effects on cell spreading are indications in support of the proposed
functional interaction between liprin-a1 and GIT1.
Figure 2. GIT1 and LAR depletion inhibit cell spreading and prevent enhanced spreading by liprin-a1 overexpression. (A) Specific and
control (Luc=luciferase) siRNA duplexes were used to downregulate the expression of endogenous GIT1, GIT2, liprin-a1 and LAR in COS7 cells. Cells
were lysed 2 days after transfection with siRNAs. After SDS-PAGE and blotting of 50 mg of each lysate, filters were incubated with antibodies for the
indicated proteins. For each specific siRNA, we could only detect the downregulation of the specific target proteins with respect to the other
endogenous proteins tested as controls. For GIT1 and GIT2, a monoclonal antibody recognizing both proteins was used here. (B) The signal for
endogenous GIT (red) is strongly decreased at paxillin-positive (green) focal adhesions following transfection with siRNA for either GIT1 (top) or LAR
(bottom) when compared to control cells (middle). Scale bar, 5 mm. (C) COS7 cells were trypsinized 2 days after co-transfection with the indicated
siRNAs and bgalactosidase (bGal), and plated 1 h on FN before immunostaining. Scale bar, 20 mm. (D, E) Quantification of spreading after replating
1 h on FN of cells co-transfected for 2 days with siRNAs (D: means 6SEM; n=100 cells per condition), or with siRNAs and plasmids for either
bgalactosidase or liprin-a1 (E: means 6SEM, n=80–90 cells per condition from 2 experiments). **P,0.01.
doi:10.1371/journal.pone.0020757.g002
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cell migration
We have used a random migration assay to analyze the role of
the liprin-a1/GIT1 complex in a different motility assay. COS7
cells were poorly motile when tested in a random migration assay
on FN, while they became active after overexpression of liprin-a1
(Fig. S7). No differences were evident between cells expressing
either GFP-liprin-a1 or the GIT1 binding-deficient mutant GFP-
liprin-DCC3 (Fig. 5, A). Therefore, the interaction between liprin-
a1 and GIT1 is not essential to regulate the random motility of
COS7 cells. Similar results were obtained by using a haptotactic
transwell migration assay, in which COS7 cell migration towards a
FN-coated substrate was strongly enhanced by liprin-a1 overex-
pression, but also by the expression of the GIT1 binding-deficient
mutant liprin-DCC3 (Fig. 5, B). On the other hand, we found that
endogenous GIT1 was required for liprin-a1-enhanced migration
(Fig. 5, C). Previous findings have shown that overexpression of
GIT1 enhanced haptotactic COS7 cell migration [4] and CHO-
K1 cell migration on FN [16], while GIT1 depletion prevented
formyl-Met-Leu-Phe peptide-enhanced chemotaxis of rat baso-
philic leukaemia RBL cells [32]. Although silencing the endoge-
nous GIT1 protein did not significantly affect basal cell migration,
it prevented the potentiation of transwell migration induced by
liprin-a1 overexpression (Fig. 5, C). Altogether these data indicate
that the function of GIT1 is important for liprin-a1-mediated
migration, although a direct interaction between the two proteins
is not necessary.
Conclusions
During cell spreading and migration on extracellular matrix,
continuous reorganization of FAs and actin dynamics at the cell
front are necessary for effective protrusion [33]. Given the
implication of GIT1 and its partners paxillin and liprin-a1i n
the regulation of cell edge dynamics, the interaction of GIT1 with
either partner may represent two distinct functional states of GIT1
during cell motility. This is supported by our biochemical data
suggesting that binding of liprin-a1 competes for binding of
paxillin to the carboxy-terminal portion of GIT1 (Fig. 1, A).
Moreover, the hypothesis is also supported by the functional
analysis showing that the localization of endogenous GIT1 and
liprin-a1 is reciprocally influenced by the other partner with
respect to the paxillin- and FAK-positive FAs at the dynamic edge
of spreading cells (Figs. 3, 4). The requirement of distinct
complexes including different combinations of the partners may
be expected, if we consider the complexity of the scaffold proteins
involved and of the cellular processes underlying cell motility.
The carboxy-terminal paxillin binding region of GIT1 is critical
for GIT1 function, since mutants of GIT1 lacking this region fail
to regulate cell migration and protrusion [34]. In particular,
phosphorylation of serine 709 within the paxillin binding region is
necessary for the effects of GIT1 on protrusions and to increase its
binding to paxillin, which could target GIT1 to the leading edge of
cells [34]. Therefore,one could envisage that competitive bindingof
liprin-a1 to GIT1 displaces GIT1 from paxillin. As a consequence,
paxillin would remain at FAs while GIT1 would be recycled to the
cytoplasm. Accordingly, we found that overexpression of liprin-a1,
but not of the GIT1-deficient liprin-DCC3 mutant, was able to
dramatically displace endogenous GIT1 from FAs (Fig. 3), while
leaving paxillin at these sites (Fig. S5).
Paxillin plays a positive role in FA formation/turnover: it is one
of the earliest proteins found associated to newly formed FAs at the
protruding cell edge [35]. On the other hand, paxillin appears to
regulate also the disassembly of FAs, since lack of paxillin leads to
the formation of more stable adhesions [36]. Our previous work
Figure 3. Liprin-a1 affects the subcellular localization of
endogenous GIT. (A) Overexpression of liprin-a1 affects the
localization of endogenous GIT at peripheral FAs. COS7 cells
overexpressing either FLAG-liprin-a1 or FLAG-bgalactosidase were
plated for 1 h on FN and immunostained for the transfected protein
and for endogenous GIT. Scale bar, 20 mm. Right panel: four-fold
enlargement of the boxed field; liprin-a1 overexpression (cell with
asterisk) reduces the accumulation of GIT at newly formed FAs at the
edge of transfected cells (arrowheads). Scale bar, 5 mm. (B) Cells
transfected with FLAG-bgalactosidase, FLAG-liprin-a1, or FLAG-liprin-
DCC3 were plated for 1 h on FN before fixation and staining for the
transfected protein and for endogenous GIT and FAK proteins. Scale
bar, 20 mm. (C) High magnification of the edge of transfected cells
showing that endogenous GIT overlaps well with FAK at peripheral FAs
of FLAG-liprin-DCC3 transfected cells, while poor overlap between
endogenous GIT and FAK is seen at peripheral FAs of FLAG-liprin-a1
expressing cells. Scale bar, 10 mm. Panels on the right are 3-fold
enlargements of the areas indicated by arrowheads in the correspond-
ing images on the left.
doi:10.1371/journal.pone.0020757.g003
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deletion mutants to inhibit cell spreading correlated with their
inhibitory effects on the localization of paxillin at vinculin-positive
FAs. On the other hand, the increased ability of GIT1-C to pro-
mote spreading was accompanied by the enhanced localization of
paxillin at peripheral FAs [26]. Altogether, our findings support
the hypothesis that GIT1, once activated, may act as a transporter
for paxillin within the cell, while liprin-a1 negatively affects the
accumulation of endogenous GIT1 at FAs without affecting the
localization of paxillin at these sites. We have been able to show
the interaction between GIT1 and its two partners only by using
GIT1 deletion mutants corresponding to an ‘‘activated’’ form of
GIT1. It could be envisaged that endogenous GIT1 is locally acti-
vated in the cell by so far unknown mechanisms, which would
allow then the interaction of GIT1 with the distinct partners
during different phases of cell edge protrusion.
Our findings show that GIT1 and its partner liprin-a1 are both
required for the reorganization of the cell edge during spreading
on extracellular matrix, since depletion of either protein causes
a similar inhibition of cell spreading on FN. The inhibitory effects
observed on spreading are not additive after silencing both pro-
teins, while the positive effects of liprin-a1 overexpression on
spreading and migration can be prevented by the downregulation
of endogenous GIT1. These observations support the hypothesis
that the two proteins cooperate in the same pathway during COS7
cell motility.
In conclusion, the data presented in this study lead us to propose
a model in which the alternative binding of liprin-a1 or paxillin to
GIT1 plays distinct roles in different phases of the protrusive
activity of the cell. It will be interesting to test in future studies
the hypothesis that GIT1 and liprin-a1 play distinct, possibly
sequential roles during protrusion by specifically addressing the
role of each of the two scaffolds in the sequence of events leading
to cell edge protrusion.
Materials and Methods
Antibodies
The antibodies used in this study were as follows: monoclonal
antibodies (mAb) anti-FLAG M5 and M2, anti-talin, and anti-
tubulin (Sigma-Aldrich, Saint Louis, MO); anti-HA 12CA5, anti-
Myc 9E10 (Primm Biotech, Milano, Italy); anti-paxillin, anti-GIT/
PKL, anti-LAR recognizing the 150 kDa form, and mAb 9EG7
recognizing activated human b1 integrins [37] (BD Transduction
Figure 4. Expression of GIT1-C affects cell morphology and the distribution of endogenous liprin-a1. (A) COS7 cells transfected for one
day with either FLAG-GIT1, FLAG-GIT1-C, or FLAG-bGalactosidase were re-plated for 1 h on FN. Immunofluorescence for the transfected proteins
(FLAG), paxillin, and phalloidin staining for F-actin. Scale bar, 20 mm. Below, 3-fold enlargements of areas from cells stained for paxillin (arrowheads in
the corresponding cells above) are shown. (B) Expression of GIT1-C induces a significant increase of cell spreading on FN. Bars are means 6 SEM
(n=116–121 cells per condition); *P,0.05. (C) Cells transfected with either FLAG-bGalactosidase or FLAG-GIT1-C were used for triple
immunofluorescence staining with antibodies for endogenous liprin-a1, paxillin, and transfected proteins (FLAG): endogenous liprin-a1 accumulates
at the edge of GIT1-C-transfected cells. Scale bar, 5 mm.
doi:10.1371/journal.pone.0020757.g004
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FLAG and anti-actin (Sigma-Aldrich); anti-FAK and anti-GIT1
(Santa Cruz Biotechnology, Santa Cruz, CA); pAbs for bPIX,
GIT1, GIT2, and liprin-a1 were described previously [11,29,38–
39]. FITC- and TRITC-conjugated phalloidin were from Sigma-
Aldrich.
DNA constructs and siRNAs
Several constructs derived from GIT1 (Fig. S1, H) were cloned
into the pFLAG-CMV2 vector (Eastman Kodak, Inc. Rochester,
NY) or into the pBK-haemagglutinin (HA) vector derived from
pBK-CMV (Stratagene, Santa Clara, CA). Full length, deletion
mutants, and fragments of liprin-a1 were cloned into the pFLAG-
Figure 5. GIT1 is required for liprin-a1-enhanced COS7 cell migration. (A) Transfected cells were replated on 10 mg/ml FN for 50 min to
allow spreading, and then monitored for motility for 2.5 h by taking one frame every 5 min. The upper panels show cell tracks from cells transfected
with the indicated constructs. The lower panel shows the quantification (mean values 6SEM) of different parameters of random migration including
cell tracks (path), Euclidean distance (displ.), path rate (Vp), Euclidean rate (Vd) and persistence of migration (persist=path/displ.). N=18–20 cells per
experimental condition; *P,0.05. (B) Transwell migration assays with cells transfected with GFP, GFP-liprin-a1, or GFP-liprin-DCC3. Bars are
normalized means 6 SEM (n=4); *P,0.05; **P,0.01. (C) Transwell migration assays with cells cotransfected with the indicated combinations of
siRNAs and plasmids. Bars are normalized means 6 SEM (n=4); *P,0.05.
doi:10.1371/journal.pone.0020757.g005
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gen, Paisley, Scotland, UK). The cDNA for GIT1-C2 was cloned
into the pQE60ZZ vector, derived from pQE60 (Qiagen, Hilden,
Germany) including the sequence coding for a ‘‘ZZ’’ tag (two
consecutive IgG binding domains of protein A), to obtain the
pQE60ZZ-GIT1-C2 plasmid. SiRNA for liprin-a1 and LAR
were previously described [11]. The GIT1a and GIT1b siRNAs
(Invitrogen) targeted the sequences 59-GCCTGGATGGAGA-
CCTAGA-39 and 59-AGCCAACCCCCAAGACAAATT -39 of
human green monkey GIT1, respectively.
Cell culture and transfection
COS7 and HeLa cells (from the American Type Culture
Collection, Teddington, UK) were grown in Dulbecco’s modified
Eagle’s medium (Cambrex Bio Science Verviers SPRL, Charles
City, IA) with 10% serum. Cells transfected with Lipofectamine
2000TM (Invitrogen) or Fugene (Roche, Manheim, Germany) and
2–3 mg of plasmids, or siRNAs (50–100 nM) were used after 1–2
days, respectively.
Immunoprecipitation and immunoblotting
Cells were lysed with 0.5–1% Triton X-100, 20 mM Tris-HCl
pH 7.5, 150 mM NaCl, 1 mM sodium orthovanadate, 10 mM
sodium fluoride, and protease inhibitors. Aliquots of 200–1,000 mg
of each lysate were incubated with the indicated antibodies pre-
bound to Protein A-Sepharose beads (Amersham, Little Chalfont,
UK). Immunoprecipitation of endogenous paxillin was performed
by conjugating protein A Sepharose beads to 2 ml of rabbit anti-
mouse Ig (Sigma-Aldrich) and 1 mg of anti-paxillin mAb (BD Bio-
sciences Transduction Laboratories). For immunoblotting primary
antibodies were visualized by ECL or
125I-anti-mouse Ig or
Protein A (Amersham).
Mass spectroscopy analysis
BL21 bacteria transformed with pQE60ZZ-GIT1-C2 were used
to express the ZZ-GIT1-C2 fusion protein upon induction with
IPTG. The ZZ-GIT1-C2 fusion protein includes a carboxy-
terminal GIT1 fragment linked to two consecutive IgG binding
domains of protein A. Bacteria were lysed and the fusion protein
was purified on IgG Sepharose 6 beads (Amersham). For the
purification of ZZ-GIT1-C2-binding proteins, all procedures were
carried at 0–4uC. 45 mg of protein from E12-E13 chick brain
lysate (lysis buffer: 1% Triton X-100, 20 mM Tris-HCl pH 7.5,
150 mM NaCl, 0.1 mM DTT, 10 mM sodium orthovanadate,
1 mM sodium fluoride, anti-protease mixture) were incubated
with ZZ-GIT1-C2 preadsorbed to 75 ml of IgG-beads. After
incubation for 1.5 h with rotation, beads were washed, transferred
to a column, further washed thoroughly, and eluted twice with
0.5 M acetic acid (pH 3.4). Control samples included IgG
Sepharose beads incubated with brain lysate (in the absence of
ZZ-GIT1-C2 protein), and IgG Sepharose beads coated with ZZ-
GIT1-C2 protein (in the absence of brain lysate). One fourth of
each eluate and of the beads left after elution with acetic acid were
analyzed by SDS-PAGE on 6% acrylamide gels.
For protein identification, bands of interest were excised from
silver-stained SDS–PAGE gels, reduced, alkylated and digested
overnight with bovine trypsin as described elsewhere [40]. One ml
of the supernatant of the digestion was used for MALDI-time of
flight mass spectrometer (TOF MS) analysis using the dried dro-
plet technique and a-cyano-4-hydroxycinnamic acid as matrix. All
analyses were performed using a Voyager-DE STR (Applied
Biosystems) TOF MS operated in the delayed extraction mode.
Peptides were measured in the mass range from 750 to 4,000 Da;
all spectra were internally calibrated and processed via the Data
Explorer software. Proteins were unambiguously identified by
searching a comprehensive non-redundant protein database using
the program ProFound [41].
Cell spreading assays
Cells were trypsinized 1–2 days after transfection. 25,000–30,000
cells were plated on 13 mm diameter coverslips coated with 10 mg/
ml FN. Cells were fixed after 1 h and processed for immuno-
fluorescence. Images were analyzed with ImageJ (Bethesda, MD).
Significance was set at P,0.05, by the Student’s t test.
Haptotactic and random migration assay
Transfected cells were incubated overnight in serum-free
medium, trypsinized, and 30,000 cells/transwell were seeded in
serum-free medium (8 mm pore PET membrane, Millipore,
Billerica, MA). The lower side of the chambers were coated with
20 mg/ml of FN, and filled with DMEM without serum. After 8 h
at 37uC non-migrating cells were removed from the upper
chamber, and cells on the lower side were fixed with 3% para-
formaldehyde and detected by immunofluorescence. For quanti-
fication, GFP positive cells were counted from 6 representative
fields per well (206lens). Data were collected from 4 independent
experiments, each in duplicate. Values of migrated cells were
normalized with respect to the percentage of transfected cells
(between 30 and 60% transfection efficiency). Random migration
was performed and quantified as previously described [24].
Morphological analysis
Ventral plasma membranes were prepared by hypotonic shock
of COS7 cells as previously described [11,30]. Cells and ventral
plasma membranes were incubated with the indicated antibodies
after fixation. F-actin was revealed by FITC- or TRITC-
conjugated phalloidin. Cells were observed with Axiophot or
Axiovert microscopes (Zeiss, Oberkochen, Germany), or confocal
microscopes (PerkinElmer, Waltham, MA and Leica Microsystems
GmbH, Wetzlar, Germany). For immunofluorescence, images
within the same panels were acquired and treated identically
for comparisons. Images were processed using Photoshop (Adobe)
and analyzed for cell spreading and FA area with ImageJ as
described before [11]. Data in the bar graphs are expressed as
mean 6 SEM from at least 2–3 repetitions in which 70–150 cells
per experimental conditions were analyzed. Random migration
was analyzed as previously described [24]. P values were calcu-
lated by the Stutent’s t-test (two-tailed distribution, two-sample
unequal variance).
Supporting Information
Figure S1 Characterization of the binding of liprin-a to
GIT1-derived polypeptides. (A–B) Interaction of liprin-a with
GIT1-C2. Lane 1, control IgG-beads coated with the ZZ-GIT1-
C2 fusion protein; lane 2, IgG-beads coupled to the ZZ-GIT1-C2
fusion protein and incubated with 45 mg of E15 chicken brain
lysate; lane 3, control IgG-beads incubated with 45 mg of E15
chicken brain lysate without the ZZ-GIT1-C2 fusion protein. After
washing, in lane 2, a band of about 160 kDa was specifically eluted
with respect to the control lanes 1 and 3. Analysis by mass
spectroscopy identified the avian 160 kDa polypeptide (asterisk) as
a close homologue of human liprin-a2. (B) Aminoacid sequence of
human liprin-a2. In grey are indicated the peptides corresponding
to the highly homologous avian peptides identified by mass
spectroscopy of the 160 kDa eluted from the IgG-beads coupled to
the ZZ-GIT1-C2 fusion protein and incubated with E15 chicken
brain lysate (see lane 2 of panel A). (C–E) Liprin-a1 and paxillin
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from lysates of COS7 cells transfected with the indicated FLAG-
GIT1-derived constructs alone or in combination with Myc-liprin-
F3. After immunoprecipitation of either liprin-F3 (anti-Myc Ab) or
endogenous paxillin, filters with immunoprecipitates and lysates
were probed by immunoblotting for liprin-F3, GIT1 constructs, or
endogenous paxillin. The data in (C–E) show that the liprin
fragment F3 interacts with GIT1-C2, but not with shorter
fragments of the carboxyterminus of GIT1. On the other hand,
paxillin is also able to bind weakly to the shorter carboxyterminal
GIT1(512–740) fragment. (F) Lysates (300 mg) from cells trans-
fected with either FLAG-GIT1-C2 or FLAG-GIT1-C were
immunoprecipitated with antibodies for endogenous paxillin (left)
or endogenous liprin-a1 (center). Immunoprecipitates and lysates
were then blotted with anti-FLAG antibodies to identify the
transfected FLAG-GIT1 constructs. The results show that both
endogenous paxillin and endogenous liprin-a bind the carbox-
yterminal GIT1 constructs. Lysates (50 mg each) are shown to the
right. (G) Scheme of the liprin-a1 and liprin-F3 constructs. (H)
Summary of some of the constructs tested: a more extended
carboxy-terminal portion of GIT1 is required for binding to liprin-
a compared to paxillin. ArfGAP, ArfGAP domain; Ank’s, ankyrin
repeats; SHD, Spa2 homology domain; CC coiled coil region;
PBD, paxillin binding domain.
(TIF)
Figure S2 Silencing of GIT1 with either of two different
siRNAs inhibits cell spreading. Left: equal amounts of
protein lysates from COS7 cells transfected with the indicated
siRNA were immunoblotted for GIT proteins (upper filter) or
tubulin (lower filter). Molecular weight markers are indicated on
the left. Right: quantification of the effects of control and GIT1-
specific siRNAs on spreading of cells plated 1 h on FN (n=70–150
cells per condition from 2–3 experiments). *P,0.05; **P,0.01.
(TIF)
Figure S3 The GIT1-binding liprin-F3 fragment is
sufficient to enhance cell spreading. (A) FLAG-tagged
liprin-a1 constructs used in this study. (B) Transfected COS7 cells
were plated for 1 h on FN. Scale bar, 20 mm. (C) Quantification of
spreading after 1 h on FN. Bars are mean values 6 SEM (n=50
cells; **P,0.01).
(TIF)
Figure S4 Effects of liprin-DCC3 expression on spread-
ing. (A) Lysates from cells transfected with GIT1-C2, GIT1-C2
and liprin-a1, or GIT1-C2 and liprin-DCC3 (schemes under
the blots) were immunoprecipitated (IP) with anti-liprin-a1 anti-
bodies. Filters were analyzed by immunoblotting for the indicated
antigens. (B) Immunostaining for liprin of ventral plasma mem-
branes prepared as described in the Methods, starting from cells
transfected with either full length liprin-a1 or liprin-DCC3. Scale
bar, 20 mm. (C) Cells transfected with bgalactosidase, liprin-a1, or
liprin-DCC3 were plated 1 h on FN and stained for the transfected
protein (left) and F-actin (right). (D) Quantification of spreading in
cells treated as described in (C). Bars are mean values 6 SEM
(n=150 cells from 3 experiments). (E) Cells transfected with the
indicated constructs and plated 1 h on FN were fixed and
evaluated for the presence of lamellipodia, measured as the
percentage of F-actin-positive cell perimeter. Bars are means 6
SEM (n=20 cells from 2 experiments). *P,0.05; **P,0.01.
(TIF)
Figure S5 Liprin-a1 affects the distribution of FAs and
activated integrin receptors at the cell edge in a GIT1-
independent way. (A) COS7 cells plated for 1 h on FN, and
stained with the 9EG7 mAb specific for activated b1 integrins.
Scale bar, 20 mm. (B) Distribution of paxillin-positive peripheral
FAs at the edge of cells transfected with GFP, GFP-Liprin-a1, or
GFP-Liprin-DCC3, and plated for 1 h on FN. Scale bar, 10 mm.
(C–D) Quantification of active b1 integrin-positive FAs from trans-
fected cells as those shown in (A): (C) fraction of projected cell area
occupied by active b1-integrin-positive FAs; (D): percentage of FA
area at the cell edge. Bars are means 6 SEM (n=24 cells per
condition). *P,0.05; **P,0.01. (E) Percentage of spreading cells
with either high (grey) or low (dark grey) FA density at the edge
(n=26 fields from 13 cells per condition; *P,0.001 by the x2 test).
(TIF)
Figure S6 Distribution of FA proteins in HeLa cells
overexpressing liprin-a1. HeLa cells overexpressing either
FLAG-liprin-a1 or FLAG-bgalactosidase were plated for 1 h on
FN and immunostained for the transfected protein and for the
indicated endogenous proteins. While endogenous GIT was
displaced from peripheral FAs in cells overexpressing liprin-a1,
the localization at FAs of other endogenous components was not
evidently affected. Asterisks indicate transfected cells. Scale bar,
20 mm.
(TIF)
Figure S7 Effects of liprin-a1 overexpression on COS7
cell motility. COS7 cells transfected with GFP or GFP-Liprin-
a1 were plated 50 min on 10 mg/ml FN before time-lapse analysis
at the indicated time points. Scale bar, 10 mm.
(TIF)
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